Regeneron (NASDAQ: REGN) is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led for over 35 years by physician-scientists, our unique ability to repeatedly and consistently translate science into medicine has led to numerous FDA-approved treatments and product candidates in development, almost all of which were homegrown in our laboratories. Our medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, hematologic diseases, infectious diseases and rare diseases.
Shared 22 hours ago
21 views
Shared 4 weeks ago
151 views
Shared 1 month ago
130 views
Shared 2 months ago
76K views
Shared 2 months ago
419 views
Shared 3 months ago
542 views
Shared 3 months ago
580 views
Shared 3 months ago
607 views
Shared 4 months ago
144K views
Shared 4 months ago
746 views
Shared 4 months ago
372 views
Shared 5 months ago
209K views
Shared 6 months ago
327 views
Shared 8 months ago
473K views
Shared 8 months ago
224 views
Shared 8 months ago
98 views
Shared 9 months ago
820 views
Shared 9 months ago
2K views
Shared 10 months ago
432 views
Shared 11 months ago
605 views
Shared 11 months ago
119K views
Shared 11 months ago
154 views
Shared 1 year ago
41K views